Recombinase Brec1 trend-setting for future HIV therapy
Researchers at the Medical Faculty of the Technische Universität Dresden (TUD) and the Heinrich Pette Institute (HPI), Leibniz Institute for Experimental Virology succeeded in developing a designer recombinase (Brec1) that ...
Feb 22, 2016
0
131